SHL Telemedicine Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	39	44	43	114	216	276
Market Cap Growth	34.50%	2.61%	-62.59%	-47.37%	-21.68%	121.10%
Enterprise Value	29	45	43	112	223	248
Last Close Price	1.05	1.18	1.43	3.82	8.14	10.51
Forward PE	-	7.31	7.31	7.31	7.31	7.31
PS Ratio	0.84	0.94	0.83	2.37	3.97	6.11
PB Ratio	1.12	1.26	1.20	1.77	3.95	4.99
P/TBV Ratio	3.79	4.26	4.12	4.48	23.91	78.41
P/OCF Ratio	-	-	-	-	-	1638.60
EV/Sales Ratio	0.63	0.96	0.84	2.34	4.08	5.49
EV/EBITDA Ratio	-	-	-	-	-	62.62
EV/EBIT Ratio	-	-	-	-	-	1290.94
Debt / Equity Ratio	0.30	0.30	0.41	0.26	0.45	0.54
Debt / EBITDA Ratio	-	-	-	-	192.39	7.47
Net Debt / Equity Ratio	-0.28	-0.28	-0.04	-0.08	0.14	0.01
Net Debt / EBITDA Ratio	4.40	4.40	0.23	1.18	-3.31	0.10
Net Debt / FCF Ratio	3.67	3.67	1.06	2.30	-4.64	-1.00
Asset Turnover	0.71	0.71	0.59	0.51	0.49	0.51
Inventory Turnover	24.89	24.89	13.39	8.67	7.87	8.97
Quick Ratio	1.18	1.18	0.95	2.05	1.56	2.37
Current Ratio	1.25	1.25	1.03	2.30	1.81	2.64
Return on Equity (ROE)	-37.04%	-37.04%	-47.97%	-10.10%	0.36%	-28.23%
Return on Assets (ROA)	-4.37%	-4.37%	-5.59%	-4.34%	-2.69%	0.14%
Return on Invested Capital (ROIC)	-18.29%	-16.64%	-16.06%	-11.31%	-1.32%	0.41%
Return on Capital Employed (ROCE)	-10.40%	-10.40%	-16.00%	-8.10%	-5.60%	0.20%
Earnings Yield	-31.34%	-27.88%	-59.74%	-5.22%	-0.03%	-4.66%
FCF Yield	-6.77%	-6.02%	-2.81%	-2.06%	-0.74%	-0.14%
Buyback Yield / Dilution	-30.75%	-30.75%	-0.59%	-7.22%	-7.71%	-34.33%
Total Shareholder Return	-30.75%	-30.75%	-0.59%	-7.22%	-7.71%	-34.33%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.